{
    "2019-11-22": [
        [
            {
                "time": "2019-05-24",
                "original_text": "Pharma Stock Roundup: FDA Nod to NVS & AZN's Drugs, BMY-CELG Merger Closes",
                "features": {
                    "keywords": [
                        "FDA",
                        "NVS",
                        "AZN",
                        "Drugs",
                        "BMY-CELG",
                        "Merger"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-05-24",
                "original_text": "AstraZeneca shares rise on early U.S. approval for leukemia drug",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "shares",
                        "rise",
                        "U.S.",
                        "approval",
                        "leukemia",
                        "drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}